Deepak Shukla

Title: Deepak Shukla: Innovator in Viral Infection Prevention

Introduction

Deepak Shukla is a notable inventor based in Orland Park, IL (US). He has made significant contributions to the field of viral infection prevention, holding a total of 3 patents. His work focuses on innovative methods to combat viral infections, particularly those caused by herpes simplex virus.

Latest Patents

One of Deepak Shukla's latest patents involves the development of anti-heparan sulfate peptides that block herpes simplex virus infection in vivo. This patent provides methods that utilize these peptides for the prevention or treatment of various viral infections, including herpesviral infections exemplified by HSV-1, CMV, and HHV-8. The peptides consist of at least 10 amino acids from specific sequences, which may be coupled with therapeutic compounds to enhance their effectiveness. Another significant patent he holds is related to virus traps, which are designed to capture viral particles using particles and particle agglomerates with semiconductor surfaces. These innovations can be used therapeutically and prophylactically to treat or prevent viral infections, as well as for research and diagnostic purposes.

Career Highlights

Deepak Shukla has worked at prestigious institutions such as the University of Illinois and the University of North Carolina at Chapel Hill. His research and inventions have contributed to advancements in the understanding and treatment of viral infections.

Collaborations

Throughout his career, Deepak has collaborated with notable colleagues, including Vaibhav Tiwari and Anders Malmström. These collaborations have further enriched his research and innovation efforts.

Conclusion

Deepak Shukla's work in the field of viral infection prevention showcases his dedication to innovation and research. His patents reflect a commitment to developing effective solutions for combating viral diseases.